20 March 2025 in Veterinary Anaesthesia and Analgesia
To create data-driven clinical pathology thresholds for routine blood tests to assess perianesthetic mortality risk in dogs and cats undergoing elective procedures. Retrospective analysis. Data from dogs and cats visiting Banfield hospitals between January 2019 and March 2023. Using routinely collected veterinary data from dogs and cats undergoing elective procedures at primary care veterinary practices, data-driven clinical pathology thresholds were calculated to identify perianesthetic mortality risk. This process involved simulation from a generalized additive model that estimated perianesthetic mortality risk, based on signalment data, procedure type, physical status classification and blood analyte values, with data collected between January 2019 and March 2023. The simulated data was used to test 400 potential thresholds. Optimal thresholds were chosen to maximize sensitivity (proportion of deaths correctly predicted) subject to limits on false positive rate (number of non-deaths incorrectly identified). These optimal limits were evaluated on observed data. Two levels of data-driven clinical pathology thresholds were determined, 'stop' and 'critical stop', with the latter more stringent. For the 'stop' limits, the overall median sensitivity on observed data was 7.16% (interquartile range 4.29%-9.88%) and 11.80% (11.00%-14.60%) for dogs and cats, respectively, and the overall median false positive rate was 2.65% (2.40%-3.31%) and 8.25% (6.86%-9.66%) for dogs and cats, respectively. Albumin, hematocrit, neutrophils and white blood cells were identified as having strong evidence for their utility in creating thresholds for dogs. Neutrophils showed strong evidence for thresholds for cats. These new data-driven thresholds offer more consistent and quantifiable false positive rates and increased sensitivities compared with existing limits. However, weaker evidence resulted in fewer useful thresholds for cats owing to lower data availability. It is possible to use routinely collected data to create data-driven clinical pathology thresholds for blood tests to identify animals at increased risk of perianesthetic mortality.
1 March 2025 in American Journal of Veterinary Research
OBJECTIVE: To evaluate the use of collar-mounted accelerometers to objectively monitor treatment outcomes in canine pruritus. METHODS: Observational data from 1,803 dogs from 2019 through 2023 were retrospectively analyzed to evaluate the efficacy of collar-mounted accelerometers to assess treatment efficacy for pruritic canine skin diseases. Accelerometer measurements were joined to electronic health records to establish symptoms, diagnoses, and interventions. A directed acyclic graph was used to identify relevant variables to control for, and linear regression was used to model the pruritic behaviors before and after intervention. RESULTS: Significant reductions in pruritic behaviors, particularly scratching and licking, were observed following interventions. Antibody and immunosuppressant treatments exhibited the most pronounced effects on scratching behavior, with a reduction in scratching of up to 40.9% and 23.4%, retrospectively, in the 30 days following intervention relative to the 14 days prior. CONCLUSIONS: Collar-mounted accelerometers used to measure pruritic behaviors can detect the effects of interventions for canine pruritus. CLINICAL RELEVANCE: Pruritus is a common symptom of canine skin diseases, such as atopic dermatitis or allergic dermatitis, which can be difficult to diagnose and manage. This study highlights the use of collar-mounted accelerometers to objectively monitor treatment outcomes for canine pruritus, providing valuable insights into treatment effectiveness that could allow veterinarians and pet owners to optimize management strategies to alleviate the burden of this challenging condition.